Stock ARWR ARROWHEAD PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
25.22 USD +0.88% Intraday chart for Arrowhead Pharmaceuticals, Inc. +8.85% -17.58%
May. 03 Arrowhead Nets $50 Milestone Payment from Royalty Pharma After Completion of Enrollment in Trial of Cardiovascular Drug MT
Apr. 24 Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ARROWHEAD PHARMACEUTICALS, INC.
Bio Therapeutic Drugs
+0.88%+8.85%-17.58%-37.65%+37.59% 3.1B
Bearish
Neutral
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ARWR Stock
  4. Charts Arrowhead Pharmaceuticals, Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW